| Original language | English |
|---|---|
| Pages (from-to) | 552-554 |
| Number of pages | 3 |
| Journal | American Journal of Kidney Diseases |
| Volume | 63 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2014 |
| Externally published | Yes |
Isn't it ironic? Cost-effectiveness and willingness to pay for tolvaptan in the prevention of kidney failure in autosomal dominant polycystic kidney disease
Robert Nee, Christina M. Yuan, Kevin C. Abbott*
*Corresponding author for this work
Research output: Contribution to journal › Editorial
3
Scopus
citations